Improving Treatment for Pediatric Cardiomyopathy

Video

Recent research shows that advances in treatment are leading to improved survival rates for children with dilated cardiomyopathy, even among those patients who do not receive a heart transplant.

Recent research shows that advances in treatment are leading to improved survival rates for children with dilated cardiomyopathy, even among those patients who do not receive a heart transplant.

Rakesh Singh, MD, MS, discussed some of these new developments in treatment during the 2014 American Heart Association Scientific Sessions in Chicago.

Related Videos
Ricky Safer: What Clinicians Need to Know About PSC
Guillaume Lassailly: How Do We Value Bariatric Surgery in 2023?
© 2023 MJH Life Sciences

All rights reserved.